These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6203306

  • 1. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy.
    Bruze M, Krook G, Ljunggren B.
    Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306
    [Abstract] [Full Text] [Related]

  • 2. Antinuclear antibodies appearing during PUVA therapy.
    Bruze M, Ljunggren B.
    Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703
    [Abstract] [Full Text] [Related]

  • 3. Antinuclear antibodies and PUVA photochemotherapy.
    Kubba R, Steck WD, Clough JD.
    Arch Dermatol; 1981 Aug; 117(8):474-7. PubMed ID: 6973321
    [Abstract] [Full Text] [Related]

  • 4. Antinuclear antibodies during Puva therapy.
    Bjellerup M, Bruze M, Forsgren A, Krook G, Ljunggren B.
    Acta Derm Venereol; 1979 Aug; 59(1):73-5. PubMed ID: 84474
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients.
    Levin DL, Roenigk HH, Caro WA, Lyons M.
    J Am Acad Dermatol; 1982 Mar; 6(3):328-33. PubMed ID: 7040505
    [Abstract] [Full Text] [Related]

  • 7. [Antinuclear antibodies and PUVA therapy].
    Cattaneo R, Pancera C, Fenini MG, Gavazzoni R, De Costanza F.
    G Ital Dermatol Venereol; 1982 Mar; 117(4):207-10. PubMed ID: 6985322
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis.
    Boer J, Hermans J, Schothorst AA, Suurmond D.
    Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B, Fischer T, Michaëlsson G, Norén P.
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
    Benhamou CL, Amor B, Menkes CJ, Delbarre F.
    Ann Med Interne (Paris); 1982 Feb; 133(2):72-9. PubMed ID: 6979281
    [Abstract] [Full Text] [Related]

  • 18. Approval of PUVA for severe psoriasis.
    FDA Drug Bull; 1982 Aug; 12(2):13-4. PubMed ID: 7141170
    [No Abstract] [Full Text] [Related]

  • 19. Ophthalmological study of patients undergoing long-term PUVA therapy.
    Rönnerfält L, Lydahl E, Wennersten G, Jahnberg P, Thyresson-Hök M.
    Acta Derm Venereol; 1982 Aug; 62(6):501-5. PubMed ID: 6187155
    [Abstract] [Full Text] [Related]

  • 20. [Connective tissue diseases and HEp-2 antinuclear antibodies].
    Scagliusi P, Anelli P, Fasiello V, De Lucia M, Pipitone V.
    Minerva Med; 1985 May 19; 76(21):999-1003. PubMed ID: 3873632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.